Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. (Q46006772)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. |
scientific article |
Statements
1 reference
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. (English)
1 reference
1 reference
Bernard Escudier
1 reference
Cezary Szczylik
1 reference
Tomasz Demkow
1 reference
Tim Eisen
1 reference
Walter M Stadler
1 reference
Stéphane Oudard
1 reference
Michael Staehler
1 reference
Sylvie Negrier
1 reference
Christine Chevreau
1 reference
Apurva A Desai
1 reference
Thomas E Hutson
1 reference
Martin Gore
1 reference
Sibyl Anderson
1 reference
Gloria Hofilena
1 reference
Minghua Shan
1 reference
Carol Pena
1 reference
Chetan Lathia
1 reference
Ronald M Bukowski
1 reference
18 May 2009
1 reference
1 reference
27
1 reference
20
1 reference
3312-3318
1 reference
Identifiers
1 reference
1 reference